State Department of Health of Rio Grande do Sul Report issue

Government Phase 3

Organization Overview

First Clinical Trial
2008
NCT01184495
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

State Secretary of Health of Rio Grande do Sul

Active Ingredients

Drugs in Phase 3 Trials (1)

epoetin (Epogen) (1 trial)

Drugs in Other Trials (2)

sofosbuvir (sovaldi) (1 trial)

velpatasvir (Epclusa) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Kidney Failure, Chronic (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3